Albumin–protamine–oligonucleotide-nanoparticles as a new antisense delivery system. Part 2: cellular uptake and effect

This publication has 25 references indexed in Scilit:

• Albumin–protamine–oligonucleotide nanoparticles as a new antisense delivery system. Part 1: Physicochemical characterization
  European Journal of Pharmaceutics and Biopharmaceutics, 2005
• Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation
  Journal of Controlled Release, 2004
• Antisense Oligonucleotides: Promise and Reality
  Annual Review of Pharmacology and Toxicology, 2001
• Cellular delivery of antisense oligonucleotides
  European Journal of Pharmaceutics and Biopharmaceutics, 2000
• Effects of NMDA-R1 antisense oligodeoxynucleotide administration: behavioral and radioligand binding studies
  Brain Research, 1997
• Phosphorothioate antisense oligodeoxynucleotides: questions of specificity
  Trends in Biotechnology, 1996
• Cloning, Functional Coexpression, and Pharmacological Characterisation of Human cDNAs Encoding NMDA Receptor NR1 and NR2A Subunits
  Journal of Neurochemistry, 1994
• Reduction of erbB2 Gene-Product in Mamma Carcinoma Cell Lines by erbB2 mRNA-Specific and Tyrosine Kinase Consensus Phosphorothioate Antisense Oligonucleotides
  Biochemical and Biophysical Research Communications, 1994
• Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions
  Nature, 1993
• The Use of Potassium Gluconate in Hypopotassemia
  Science, 1951